Cloud-clone
SKU:LMA717Mu
Magnetic Luminex Assay Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc.
Magnetic Luminex Assay Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc.
Couldn't load pickup availability
Product No.
LMA717Mu
Organism Species
Mus musculus (Mouse).
Sample Type
serum, plasma, tissue homogenates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.01-10ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.003 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc..
No significant cross-reactivity or interference between Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 87-98 | 92 |
| EDTA plasma(n=5) | 84-92 | 89 |
| heparin plasma(n=5) | 91-98 | 95 |
| sodium citrate plasma(n=5) | 79-88 | 83 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 97-105% | 85-94% | 78-95% | 81-97% |
| EDTA plasma(n=5) | 95-105% | 80-101% | 91-101% | 88-102% |
| heparin plasma(n=5) | 92-105% | 90-98% | 83-95% | 92-105% |
| sodium citrate plasma(n=5) | 87-104% | 78-92% | 98-105% | 95-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:HPRT1) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| J Crohns Colitis. | Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C. Pubmed:25518051 |
| J Crohns | Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of tenascin C PubMed: 25518051 |
| Molecular Biology Reports | Increased ENT2 Expression and Its Association With Altered Purine Metabolism in Different Stages of Colorectal Cancer Cell Lines |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA717Mu02 | Recombinant Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA717Mu01 | Recombinant Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA717Mu01 | Polyclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | WB; IHC; ICC; IP. |
| PAA717Mu02 | Polyclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | WB; IHC; ICC; IP. |
| SEA717Mu | ELISA Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA717Mu | Magnetic Luminex Assay Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
